447 related articles for article (PubMed ID: 19151620)
21. Rhabdomyosarcoma in Nijmegen breakage syndrome: strong association with perianal primary site.
Meyer S; Kingston H; Taylor AM; Byrd PJ; Last JI; Brennan BM; Trueman S; Kelsey A; Taylor GM; Eden OB
Cancer Genet Cytogenet; 2004 Oct; 154(2):169-74. PubMed ID: 15474156
[TBL] [Abstract][Full Text] [Related]
22. Nijmegen breakage syndrome in 13% of age-matched Czech children with primary microcephaly.
Seeman P; Gebertová K; Paderová K; Sperling K; Seemanová E
Pediatr Neurol; 2004 Mar; 30(3):195-200. PubMed ID: 15033202
[TBL] [Abstract][Full Text] [Related]
23. Conditional inactivation of the NBS1 gene in the mouse central nervous system leads to neurodegeneration and disorganization of the visual system.
Baranes K; Raz-Prag D; Nitzan A; Galron R; Ashery-Padan R; Rotenstreich Y; Assaf Y; Shiloh Y; Wang ZQ; Barzilai A; Solomon AS
Exp Neurol; 2009 Jul; 218(1):24-32. PubMed ID: 19345213
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of the Nijmegen breakage syndrome gene leads to excess centrosome duplication via the ATR/BRCA1 pathway.
Shimada M; Sagae R; Kobayashi J; Habu T; Komatsu K
Cancer Res; 2009 Mar; 69(5):1768-75. PubMed ID: 19244116
[TBL] [Abstract][Full Text] [Related]
25. An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viability.
Demuth I; Frappart PO; Hildebrand G; Melchers A; Lobitz S; Stöckl L; Varon R; Herceg Z; Sperling K; Wang ZQ; Digweed M
Hum Mol Genet; 2004 Oct; 13(20):2385-97. PubMed ID: 15333589
[TBL] [Abstract][Full Text] [Related]
26. siRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status.
Ohnishi K; Scuric Z; Schiestl RH; Okamoto N; Takahashi A; Ohnishi T
Radiat Res; 2006 Sep; 166(3):454-62. PubMed ID: 16972754
[TBL] [Abstract][Full Text] [Related]
27. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the TP53 gene in laser-microdissected glioblastoma vasculature.
Kulla A; Burkhardt K; Meyer-Puttlitz B; Teesalu T; Asser T; Wiestler OD; Becker AJ
Acta Neuropathol; 2003 Apr; 105(4):328-32. PubMed ID: 12624785
[TBL] [Abstract][Full Text] [Related]
30. The role of NBS1 in DNA double strand break repair, telomere stability, and cell cycle checkpoint control.
Zhang Y; Zhou J; Lim CU
Cell Res; 2006 Jan; 16(1):45-54. PubMed ID: 16467875
[TBL] [Abstract][Full Text] [Related]
31. [Genes and cancer. NBS1 (Nijmegen breakage syndrome). Repair gene].
Soussi T
Bull Cancer; 1999 Oct; 86(10):803-4. PubMed ID: 10610129
[No Abstract] [Full Text] [Related]
32. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.
Sure U; Rüedi D; Tachibana O; Yonekawa Y; Ohgaki H; Kleihues P; Hegi ME
J Neuropathol Exp Neurol; 1997 Jul; 56(7):782-9. PubMed ID: 9210874
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL).
Varon R; Reis A; Henze G; von Einsiedel HG; Sperling K; Seeger K
Cancer Res; 2001 May; 61(9):3570-2. PubMed ID: 11325820
[TBL] [Abstract][Full Text] [Related]
34. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
[TBL] [Abstract][Full Text] [Related]
35. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
[TBL] [Abstract][Full Text] [Related]
36. Lack of mutations in the TP53 tumor suppressor gene exons 5 to 8 in Fanconi's anemia.
Jonveaux P; Le Coniat M; Grausz D; Berger R
Nouv Rev Fr Hematol (1978); 1991; 33(5):343-5. PubMed ID: 1803324
[TBL] [Abstract][Full Text] [Related]
37. Detection of somatic TP53 splice site mutations in diffuse astrocytomas.
Uno M; Oba-Shinjo SM; de Aguiar PH; Leite CC; Rosemberg S; Miura FK; Junior RM; Scaff M; Nagahashi Marie SK
Cancer Lett; 2005 Jun; 224(2):321-7. PubMed ID: 15914282
[TBL] [Abstract][Full Text] [Related]
38. A case report of a patient with microcephaly, facial dysmorphism, chromosomal radiosensitivity and telomere length alterations closely resembling "Nijmegen breakage syndrome" phenotype.
Berardinelli F; di Masi A; Salvatore M; Banerjee S; Myung K; De Villartay JP; Revy P; Plebani A; Soresina A; Taruscio D; Tanzarella C; Antoccia A
Eur J Med Genet; 2007; 50(3):176-87. PubMed ID: 17395558
[TBL] [Abstract][Full Text] [Related]
39. MRI evidence of white matter damage in a mouse model of Nijmegen breakage syndrome.
Assaf Y; Galron R; Shapira I; Nitzan A; Blumenfeld-Katzir T; Solomon AS; Holdengreber V; Wang ZQ; Shiloh Y; Barzilai A
Exp Neurol; 2008 Jan; 209(1):181-91. PubMed ID: 17976584
[TBL] [Abstract][Full Text] [Related]
40. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
